Kevin Outterson

Citirano

	Sve	Od 2020.
Citati	11513	8619
H-indeks	40	28
i10-indeks	70	50

2000

1000

500

1500

20052006200720082009201020112012201320142015201620172018201920202021202220232024202529 42 55 49 90 85 105 116 145 167 205 286 269 401 665 1213 1468 1816 1852 1964 289

Javni pristup

Prikaži sve

27 članaka

3 članka

dostupno

nije dostupno

Na temelju uvjeta financiranja

Suautori

Ramanan LaxminarayanOne Health Trust/Princeton UniversityPotvrđena adresa e-pošte na onehealthtrust.org
John-Arne RøttingenPotvrđena adresa e-pošte na hks12.harvard.edu
Steven J. HoffmanProfessor of Global Health, Law, and Politics, York University, CanadaPotvrđena adresa e-pošte na globalstrategylab.org
Aaron KesselheimProfessor of Medicine, Harvard Medical School & Brigham and Women's HospitalPotvrđena adresa e-pošte na partners.org
Ursula TheuretzbacherCenter for Anti-Infective Agents, ViennaPotvrđena adresa e-pošte na aon.at
Evan SelingerProfessor of Philosophy, Rochester Institute of TechnologyPotvrđena adresa e-pošte na rit.edu
Chantal M MorelPotvrđena adresa e-pošte na unibe.ch
Nicole HuberfeldProfessor of Health Law, Ethics & Human Rights and Professor of Law, Boston UniversityPotvrđena adresa e-pošte na bu.edu
Francesco CiabuschiUppsala UniversityPotvrđena adresa e-pošte na fek.uu.se
Kyle WhyteUniversity of MichiganPotvrđena adresa e-pošte na umich.edu
Enrico BaraldiUppsala universityPotvrđena adresa e-pošte na angstrom.uu.se
Bernard MunosSenior Fellow, FasterCures (a center of the Milken Institute)Potvrđena adresa e-pošte na stanfordalumni.org
Rosa Rodriguez-Monguio, PhD, MSProfessor & Director Medication Outcomes CenterPotvrđena adresa e-pošte na ucsf.edu
Enrique Seoane VazquezChapman University School of PharmacyPotvrđena adresa e-pošte na chapman.edu
Aidan HollisProfessor of Economics, University of CalgaryPotvrđena adresa e-pošte na ucalgary.ca
Thomas PoggeLeitner Professor of Philosophy and International AffairsPotvrđena adresa e-pošte na yale.edu
Laura PiddockProfessor of Microbiology, University of BirminghamPotvrđena adresa e-pošte na bham.ac.uk
ian gouldaberdeenPotvrđena adresa e-pošte na modusmedica.com
Christopher RobertsonBoston University LawPotvrđena adresa e-pošte na BU.EDU
Anthony McDonnellFellowPotvrđena adresa e-pošte na cgdev.org

Prati

Kevin Outterson

Boston University

Potvrđena adresa e-pošte na bu.edu - Početna stranica

Pharmaceutical innovation antibiotic resistance healthcare organization and finance


Naslov Poredaj po navodima Poredaj po godini Poredaj po naslovu	Citirano Citirano	Godina
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ... The Lancet infectious diseases 18 (3), 318-327, 2018	5999	2018
The global preclinical antibacterial pipeline U Theuretzbacher, K Outterson, A Engel, A Karlén Nature Reviews Microbiology 18 (5), 275-285, 2020	684	2020
Antibiotic development—economic, regulatory and societal challenges C Årdal, M Balasegaram, R Laxminarayan, D McAdams, K Outterson, ... Nature Reviews Microbiology 18 (5), 267-274, 2020	401	2020
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later R Laxminarayan, T Van Boeckel, I Frost, S Kariuki, EA Khan, ... The Lancet Infectious Diseases 20 (4), e51-e60, 2020	275	2020
Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets K Outterson Yale J. Health Pol’y L. & Ethics 5, 193, 197, 2005	267	2005
International cooperation to improve access to and sustain effectiveness of antimicrobials C Årdal, K Outterson, SJ Hoffman, A Ghafur, M Sharland, N Ranganathan, ... The Lancet 387 (10015), 296-307, 2016	195	2016
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward AK Nanayakkara, HW Boucher, VG Fowler Jr, A Jezek, K Outterson, ... CA: a cancer journal for clinicians 71 (6), 488-504, 2021	160	2021
An international legal framework to address antimicrobial resistance SJ Hoffman, K Outterson, JA Røttingen, O Cars, C Clift, Z Rizvi, F Rotberg, ... Bulletin of the World Health Organization 93, 66-66, 2015	149	2015
The ethics of poverty tourism E Selinger, K Outterson Boston University School of Law Working Paper, 2009	143*	2009
Plunging into Endless Difficulties: Medicaid and Coercion in National Federation of Independent Business v. Sebelius N Huberfeld, EW Leonard, K Outterson BUL Rev. 93, 1, 2013	133*	2013
Repairing the broken market for antibiotic innovation K Outterson, JH Powers, GW Daniel, MB McClellan Health affairs 34 (2), 277-285, 2015	127	2015
Progress in the fight against multidrug-resistant bacteria? A review of US Food and Drug Administration–approved antibiotics, 2010–2015 D Deak, K Outterson, JH Powers, AS Kesselheim Annals of internal medicine 165 (5), 363-372, 2016	126	2016
Antibiotic research and development: business as usual? S Harbarth, U Theuretzbacher, J Hackett, Drive-AB Consortium, ... Journal of Antimicrobial Chemotherapy 70 (6), 1604-1607, 2015	124	2015
Towards new business models for R&D for novel antibiotics AD So, N Gupta, SK Brahmachari, I Chopra, B Munos, C Nathan, ... Drug Resistance Updates, 2011	105	2011
Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach JH Rex, K Outterson The Lancet Infectious Diseases 16 (4), 500-505, 2016	99	2016
Vanishing Public Domain: Antibiotic Resistance, Pharmaceutical Innovation and Intellectual Property Law, The K Outterson U. Pitt. L. Rev. 67, 67, 2005	96	2005
What will it take to address the global threat of antibiotic resistance? SJ Hoffman, K Outterson Journal of Law, Medicine & Ethics 43 (S3), 6-11, 2015	92	2015
Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals AS Kesselheim, K Outterson Health Affairs 29 (9), 1689-1696, 2010	92	2010
Setting the standard: multidisciplinary hallmarks for structural, equitable and tracked antibiotic policy C Kirchhelle, P Atkinson, A Broom, K Chuengsatiansup, JP Ferreira, ... BMJ Global Health 5 (9), e003091, 2020	85	2020
Designing development programs for non-traditional antibacterial agents JH Rex, H Fernandez Lynch, IG Cohen, JJ Darrow, K Outterson Nature communications 10 (1), 3416, 2019	83	2019

Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.

Članci 1–20

Godišnji broj citata

Dvostruki navodi

Spojeni navodi

Dodavanje suautoraSuautori

Prati

Citirano

Suautori